140 related articles for article (PubMed ID: 36683270)
1. Immune Checkpoint Inhibitors and Optic Neuropathy: A Systematic Review.
Pietris J; Santhosh S; Ferdinando Cirocco G; Lam A; Bacchi S; Tan Y; Gupta AK; Kovoor JG; Chan W
Semin Ophthalmol; 2023 Aug; 38(6):547-558. PubMed ID: 36683270
[TBL] [Abstract][Full Text] [Related]
2. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
3. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
4. Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors.
Vogrig A; Muñiz-Castrillo S; Joubert B; Picard G; Rogemond V; Skowron F; Egri M; Desestret V; Tilikete C; Psimaras D; Ducray F; Honnorat J
Neurology; 2021 Feb; 96(6):e866-e875. PubMed ID: 33318162
[TBL] [Abstract][Full Text] [Related]
5. Surgery for nonarteritic anterior ischemic optic neuropathy.
Dickersin K; Li T
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001538. PubMed ID: 25763979
[TBL] [Abstract][Full Text] [Related]
6. Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.
Asdourian MS; Shah N; Jacoby TV; Reynolds KL; Chen ST
JAMA Dermatol; 2022 Aug; 158(8):933-941. PubMed ID: 35612829
[TBL] [Abstract][Full Text] [Related]
7. Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies.
Noble CW; Gangaputra SS; Thompson IA; Yuan A; Apolo AB; Lee JM; Papaliodis GN; Kodati S; Bishop R; Magone MT; Sobrin L; Sen HN
Ocul Immunol Inflamm; 2020 Aug; 28(6):854-859. PubMed ID: 31013173
[TBL] [Abstract][Full Text] [Related]
8. Surgery for nonarteritic anterior ischemic optic neuropathy.
Dickersin K; Manheimer E; Li T
Cochrane Database Syst Rev; 2012 Jan; 1():CD001538. PubMed ID: 22258945
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-induced optic neuropathy - a case report.
Daetwyler E; Zippelius A; Meyer P; Läubli H
Front Immunol; 2023; 14():1171981. PubMed ID: 37228591
[TBL] [Abstract][Full Text] [Related]
10. Surgery for nonarteritic anterior ischemic optic neuropathy.
Dickersin K; Manheimer E
Cochrane Database Syst Rev; 2000; (2):CD001538. PubMed ID: 10796806
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients.
Song P; Zhang D; Cui X; Zhang L
Thorac Cancer; 2020 Sep; 11(9):2406-2430. PubMed ID: 32643323
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
Barroso-Sousa R; Barry WT; Garrido-Castro AC; Hodi FS; Min L; Krop IE; Tolaney SM
JAMA Oncol; 2018 Feb; 4(2):173-182. PubMed ID: 28973656
[TBL] [Abstract][Full Text] [Related]
13. Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer.
Shao J; Wang C; Ren P; Jiang Y; Tian P; Li W
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32315071
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.
Agostinetto E; Eiger D; Lambertini M; Ceppi M; Bruzzone M; Pondé N; Plummer C; Awada AH; Santoro A; Piccart-Gebhart M; de Azambuja E
Eur J Cancer; 2021 May; 148():76-91. PubMed ID: 33740500
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis.
Zhao Z; Zhang W; Pang L; Zeng L; Liu S; Liu J
Front Immunol; 2023; 14():1166299. PubMed ID: 37359551
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models.
Park BC; Stone CA; Dewan AK; Johnson DB
Immunol Allergy Clin North Am; 2022 May; 42(2):285-305. PubMed ID: 35469619
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors Do Not Increase Short-Term Risk of Hypertension in Cancer Patients: a Systematic Literature Review and Meta-Analysis.
Minegishi S; Kinguchi S; Horita N; Namkoong H; Briasoulis A; Ishigami T; Tamura K; Nishiyama A; Yano Y;
Hypertension; 2022 Nov; 79(11):2611-2621. PubMed ID: 36093785
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis.
Zhao Q; Zhang J; Xu L; Yang H; Liang N; Zhang L; Zhang F; Zhang X
Front Immunol; 2021; 12():730320. PubMed ID: 34646270
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T
Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
